Harbor Investment Advisory, LLC Eli Lilly & CO Transaction History

Harbor Investment Advisory, LLC

$1.14 Billion
Q2 2024

A detailed history of Harbor Investment Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 10,400 shares of LLY stock, worth $9.13 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

10,400

Previous 10,345 0.53%

Holding current value

$9.13 Million

Previous $8.05 Million 17.0%

% of portfolio

0.83%

Previous 0.7%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$724.87 - $909.04 $39,867 - $49,997	55 Added 0.53%	10,400 $9.42 Million
Q1 2024 Apr 12, 2024	BUY	$592.2 - $792.28 $249,316 - $333,549	421 Added 4.24%	10,345 $8.05 Million
Q4 2023 Jan 26, 2024	BUY	$525.19 - $619.13 $101,361 - $119,492	193 Added 1.98%	9,924 $5.78 Million
Q3 2023 Oct 13, 2023	BUY	$434.7 - $599.3 $147,798 - $203,761	340 Added 3.62%	9,731 $5.23 Million
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $59,275 - $79,257	-169 Reduced 1.77%	9,391 $4.4 Million
Q1 2023 Apr 21, 2023	BUY	$310.63 - $364.82 $237,942 - $279,452	766 Added 8.71%	9,560 $3.28 Million
Q4 2022 Jan 24, 2023	SELL	$321.55 - $374.67 $21,543 - $25,102	-67 Reduced 0.76%	8,794 $0
Q3 2022 Nov 01, 2022	SELL	$296.48 - $337.87 $117,702 - $134,134	-397 Reduced 4.29%	8,861 $2.87 Million
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $3,623 - $4,254	-13 Reduced 0.14%	9,258 $3 Million
Q1 2022 Apr 20, 2022	BUY	$234.69 - $291.66 $14,550 - $18,082	62 Added 0.67%	9,271 $2.66 Million
Q4 2021 Jan 10, 2022	SELL	$224.85 - $279.04 $61,159 - $75,898	-272 Reduced 2.87%	9,209 $2.54 Million
Q3 2021 Oct 12, 2021	SELL	$221.6 - $272.71 $37,228 - $45,815	-168 Reduced 1.74%	9,481 $2.19 Million
Q2 2021 Jul 27, 2021	BUY	$180.55 - $233.54 $424,473 - $549,052	2,351 Added 32.21%	9,649 $2.22 Million
Q1 2021 Apr 16, 2021	BUY	$164.32 - $212.72 $38,122 - $49,351	232 Added 3.28%	7,298 $1.36 Million
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $538,930 - $713,134	4,131 Added 140.75%	7,066 $1.19 Million
Q3 2020 Oct 23, 2020	BUY	$146.22 - $169.13 $189,354 - $219,023	1,295 Added 78.96%	2,935 $434,000
Q2 2020 Jul 16, 2020	BUY	$136.42 - $164.18 $14,596 - $17,567	107 Added 6.98%	1,640 $269,000
Q4 2019 Jan 16, 2020	BUY	$106.92 - $132.43 $163,908 - $203,015	1,533 New	1,533 $201,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.

Account

Harbor Investment Advisory, LLC Eli Lilly & CO Transaction History